Broker Tips
RBC stays at 'buy' on Sarepta Therapeutics, believes in 'ultimate success'
Analysts at RBC reiterated their recommendation to 'buy' shares of Sarepta, expressing confidence in the efficacy of the gene therapy specialist's muscular distrophy programmes, telling clients that they believed they would "ultimately succeed".
Broker tips: Polymetal, IMImobile
Analysts at Berenberg upped their price target on precious metals group Polymetal to 1,160p from 1,070p on Thursday, telling clients that visits to the company's Albazino and Amursk sites in Russia had confirmed its investment case.
Canaccord downgrades IMImobile to 'hold' on 'low quality' reported earnings
Analysts at Canaccord Genuity downgraded their rating on IMImobile from 'buy' to 'hold' on Thursday, stating that the group's elevated development capitalisation understated its price-to-earnings ratio.
Berenberg raises price target on Polymetal following visits to Russian sites
Analysts at Berenberg upped their price target on precious metals group Polymetal to 1,160p from 1,070p on Thursday, telling clients that visits to the company's Albazino and Amursk sites in Russia had confirmed its investment case.
Thursday broker round-up
Ferrexpo: Barclays downgrades to underweight with a target price of 110p.